关键词: 胆道癌, 美国国立综合癌症网络

Abstract:

Updates and interpretations of the NCCN Clinical Practice Guidelines 2015 on biliary tract cancers        LIU Lian-xin, LI Ke-yu.Hepatic Surgical Ward of the First Affiliated Hospital of Harbin Medical University, Harbin 150001,China
Corresponding author:LIU Lian-xin,E-mail: liulianxin@medmail.com.cn
Abstract    The updates of NCCN clinical practice guidelines in oncology 2015 V1 on biliary tract cancers include: patients with T1a stage gallbladder cancer that found on pathological review were recommended to consider adjuvant treatment in the basis of observance; gallbladder cancer patients with jaundice were recommended to consider preoperative biliary drainage if operable; adjuvant chemoradiation has been associated with survival benefit in patients with gallbladder cancer, especially in patients with lymph node-positive disease; intra-arterial chemotherapy may be used in a clinical trial in inoperable patients with intrahepatic cholangiocarcinoma while systemic or intra-arterial chemotherapy may be used in a clinical trial in patients with intrahepatic cholangiocarcinoma who found residual local disease after operation; for inoperable patients with extrahepatic cholangiocarcinoma, biliary drainage should be considered for patients with jaundice prior to instituting chemotherapy, furthermore, biopsy was recommended only after determining transplant status. NCCN clinical practice guidelines in oncology offer sufficient information for clinic, but due to the difference of race and region and the heterogeneity of tumor, the new updates would go better through the clinical practice.

Key words: biliary Tract Cancers, National Comprehensive Cancer Network (NCCN)